Apr 4 |
Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%
|
Apr 4 |
ALS drug will be pulled from US market after study showed patients didn't benefit
|
Apr 4 |
UPDATE 1-Amylyx Pharma to remove ALS drug from US, Canada markets
|
Apr 4 |
Amylyx Is Cutting 70% of Its Workforce and Pulling ALS Drug From the Market
|
Apr 4 |
Amylyx pulls ALS therapy Relyvrio from the market
|
Apr 4 |
Amylyx Pharmaceuticals Announces Formal Intention to Remove RELYVRIO®/ALBRIOZA™ from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy
|
Apr 4 |
Amylyx to pull ALS drug from market in rare move
|
Mar 27 |
European study finds popular ALS drug ineffective
|
Mar 18 |
Mizuho downgrades Amylyx to Neutral after ALS trial setback
|
Mar 14 |
3 Pharma Stocks to Sell in March Before They Crash & Burn
|